Navigation Links
Patient with rare disorder responds to cancer drug
Date:2/13/2008

A rare disorder caused by an excess of two types of immune cellsthe mast cell found in various tissues and its blood-based twin, the basophilhas successfully been treated with a cancer drug, report scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The study, now available online at the Web site of the journal Haematologica, was a collaborative effort led by Dean Metcalfe, M.D., chief of the NIAID Laboratory of Allergic Diseases and Jan Cools, Ph.D., a staff scientist, at the Katholieke Universiteit Leuven within the Vlaams Institute for Biotechnology and the Department of Molecular and Developmental Genetics, in Leuven, Belgium.

A few years ago, the 61-year-old patient was referred to the NIH Clinical Center because he was quite ill with symptoms of systemic mastocytosis, a disease caused by excessive numbers of mast cells, and chronic basophilic leukemia, a rare type of bone marrow cancer characterized by an overabundance of basophils.

Systemic mastocytosis often results from a mutation in the gene that codes for the KIT receptor found on the surface of mast cells, a discovery first made by Dr. Metcalfe and his team in 1995. In this patient, however, the KIT receptor mutation was ruled out. In further studies, NIAID researchers and their collaborators found a chromosomal abnormality that led to the discovery of a fusion protein in the cell, created by two genes joining together. They also found that the fusion protein was the basis of the disorder and figured that the patient should respond to imatinib, a drug already approved to treat different types of cancers and systemic mastocytosis. After the patient was treated with the cancer drug imatinib, his clinical symptoms improved quickly and dramatically, and he remains in clinical remission three years after treatment was started.

This is a rare report of the simultaneous occurrence of these two condit
'/>"/>

Contact: Sitara Maruf
marufs@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Marijuana Use Among MS Patients Raises Risk for Cognitive, Mood Problems
2. Tango Classes Put Parkinsons Patients a Step Ahead
3. Arizona Nurses Rally at Capitol for Patient Safety - Thursday
4. HPV-positive head and neck cancer patients fare better than HPV-negative patients
5. DCIS patients overestimate breast cancer risks
6. Anxiety linked to newly diagnosed DCIS patients overestimation of breast cancer risks
7. New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety
8. Precious Time - Scientists discover how long heart failure patients can expect to live
9. Michigan Kidney Patient Goes Above and Beyond to Help His Community - Awarded National DPC Hero Award
10. Patients with larger social networks may fare better after an operation
11. A new agent for the treatment of patients with myelodysplastic syndrome; and more
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Chinese researchers say a protein that makes ... be used as a prognostic indicator in people on chemotherapy ... full article on the study , just posted on the ... Respiratory Medicine at Shandong University Hospital in China analyzed the ... between 1995 and 2013. They found that, the lower the ...
(Date:7/30/2014)... 2014 The Independent Woman , ... holding 5 free financial workshops in the San Francisco ... goal of these workshops is our collective success, linking ... financial empowerment. , These workshops were designed by women, ... successful investor, entrepreneur, and bestselling author (Rich Woman and ...
(Date:7/30/2014)... 2014 It is often said the reason that ... be in life is because they only use about ten per ... this belief is only an erroneous myth propagated as ... they been only “smarter”. , So, success in life is defined ... to work hard for that success. Thankfully, some people have finally ...
(Date:7/30/2014)... July 30, 2014 With the ... of personal health expenditure as well as the ... system, China diagnostic reagent industry has been developing ... 90%. In 2013, Chinese in vitro diagnostics market ... came from in vitro diagnostic reagents. , ...
(Date:7/30/2014)... 30, 2014 Computer Resources of America, ... in New York City, has been awarded the contract ... headquarters of a large global bank. The bank is ... Chico Ramnarayan, CEO of CRA said, “Being awarded this ... to further develop what has already been a successful ...
Breaking Medicine News(10 mins):Health News:Study Finds Common Blood Protein May Predict Mesothelioma Survival, Reports Surviving Mesothelioma 2Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 2Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 3Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 2Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 2Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 4
... January 14, 2009 Obesity continues to increase for ... Mexican-American women. Between the ages of 35-44, there are ... and 575,000 Mexican-American women who are obese. A new ... reveals that there is an increased risk for ...
... LIVONIA, Mich., Jan. 14 On the heels of ... 11 states, American Community,Mutual Insurance Company today announced that ... Indiana. Designed to help consumer,s hold,down their medical expenses, ... through independent agents for a coverage effective date beginning,March ...
... much about it. FlameEz.com is launched to provide the latest information ... of the most feared illnesses in middle and old age. ... ... Millions of Americans are affected by chronic inflammation without knowing much ...
... SHANGHAI, China, Jan. 14 /PRNewswire-Asia-FirstCall/ -- China-Biotics, ... Company"), a leading Chinese firm,specializing in the ... products, today announced it has signed contracts,with ... Co., Ltd. ("Yuejia Food"),Shandong Huwa Dairy Industry ...
... N.Y., Jan. 14 /PRNewswire/ -- Scarguard Labs, ... of scars and other dermatological problems through the use ... system, announced it has appointed Richard E. Pino as ... Company,s finance, accounting, and treasury functions and will report ...
... in outbreak rises to 425 in 43 states, CDC says ... of people sickened by salmonella-contaminated peanut butter rose to 425 ... death in Minnesota and two in Virginia were probably tied ... the three people, whose names and hometowns haven,t been released, ...
Cached Medicine News:Health News:Economic status affects obesity rates in Mexican-American and white women 2Health News:American Community Introduces Community Flex(TM), an Affordable Health Plan in Arizona and Indiana 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 2Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 4Health News:Scarguard Labs, LLC Appoints Richard E. Pino as CFO 2Health News:Salmonella Linked to Deaths in Virginia, Minnesota 2Health News:Salmonella Linked to Deaths in Virginia, Minnesota 3
(Date:7/30/2014)... 30, 2014 Silicon Valley Bank, the bank ... today that examines the merger, acquisition and IPO ... According to the annual report based on 2013 data, ... since SVB started tracking the data in 2005. ... on solid healthcare M&A activity over the last few ...
(Date:7/30/2014)... and SAN DIEGO , July 30, ... ARNA ) announced today that an article based on ... lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and ... recently published in the online issue of Obesity , ... objective of these analyses was to identify whether there is ...
(Date:7/30/2014)... and NEW YORK , ... ACCP), a developer of new products for oncology supportive ... MuGard ® , has been featured in an article ... Mucositis Symptoms in Head and Neck Cancers."  Dr. ... provides insight on the growing demand seen in the ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... smartest choice , ... event is to ... environment. But will the device be durable enough? Can ... on its signal quality? Will the battery last? Is it comfortable, ...
... ideal as a primary chemistry-immuno analyzer ... laboratories or as a dedicated specialty ... consolidate chemistry-immuno testing with Olympus 122 ... specific proteins, esoteric chemistries and tests ...
The Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum....
... nm and 940 nm) laser system is ... solid-state laser quickly and effectively treats vascular ... offers the clinical versatility to precisely target ... vessels in a convenient, affordable package. , ...
Medicine Products: